Helixmith Co., Ltd (KOSDAQ: A084990)
Health Care · Biotechnology · KR
₩4,530.00
+22.60% today · -25.2% 1Y
Helixmith Co., Ltd (KOSDAQ: A084990) operates in the Biotechnology industry within the Health Care sector. The company is valued at $155.16M.
Over the last twelve months the share price has lost 25.2%, trading between 2.73K and 9.96K.
Tweenvest scores Helixmith Co., Ltd across four factors: quality 57/100, value 70/100. Its strongest factor is value.
A084990 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $155.16M
- Revenue (TTM)
- $1.56M
- P/E
- —
- EPS
- -34.87
- Dividend yield
- —
- Beta (5Y)
- 0.52
- 52-week high
- ₩9,960.00
- 52-week low
- ₩2,725.00
- Avg volume (3M)
- —
- Shares outstanding
- 46.05M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Coherus Oncology, Inc.NasdaqGM: CHRS | $159.14M | $1.03 | -3.74% |
| Organogenesis Holdings Inc.NasdaqCM: ORGO | $158.27M | $1.23 | -4.65% |
| Jyong Biotech Ltd.NasdaqGM: MENS | $155.89M | $2.10 | 0.00% |
| BNC KOREA, Inc.KOSDAQ: A256840 | $155.68M | ₩3,060.00 | -3.01% |
| Innovacell Inc.TSE: 504A | $155.13M | ¥544.00 | -9.63% |
| Mycenax Biotech Inc.TPEX: 4726 | $154.11M | NT$23.80 | +2.59% |
| Tiziana Life Sciences LtdNasdaqCM: TLSA | $153.88M | $1.09 | -8.40% |
| NovaBridge BiosciencesNasdaqGM: NBP | $153.12M | $1.32 | -5.38% |
Figures last refreshed Oct 11, 2026.